【英語タイトル】Pharmaceutical Vials Market Size, Share, Industry, Forecast and outlook (2024-2031)
	・商品コード：DAM7730LM092 ・発行会社（調査会社）：DataM Intelligence ・発行日：2024年9月 ・ページ数：約180 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2営業日） ・調査対象地域：グローバル ・産業分野：医療

Market Overview

Global Pharmaceutical Vials by DataM Intelligence estimates the market to grow at CAGR of 7.15% during the forecast period 2024-2031. Demand from pharmaceutical industry in North America is rising. Competitive rivalry intensifies with Stevanato Group, Gerresheimer AG, Origin Pharma Packaging and others operating in the market.

Vials are small bottles made from plastic, glass, or borosilicate to store and transport pharmaceutical drugs, powders, or tablets. Usually, this is because of their smaller size and easier to transport. Vials offer secure storage of drugs due to their high chemical resistance, limiting interactions between product and container. The vials are highly effective for low-fill applications and are ideal for sensitive drugs such as vaccines. Pharmaceutical vials also help in consuming their medications with the prescribed dosage and at the right time. The industry is making constant efforts to improve the quality of pharmaceutical vials to reduce the wastage of drugs and offer uncontaminated drugs to patients.

Market Trends and Dynamics

The global pharmaceutical vials market growth is driven by high demand from hospitals and drug manufacturers for efficient transportation, rapid Covid-19 vaccine drive in countries and prevalent endemic diseases globally.

The rapid Covid-19 vaccines drive in countries are expected to drive the demand for the pharmaceutical vials market

The pharmaceutical vials market is expected to drive with rapid Covid-19 vaccine drive in countries. According to recent data, more than 2.23 billion covid vaccine doses have been administered worldwide so far. The leading countries in terms of the fully vaccinated public are Israel, United Kingdom and Bahrain with 52%, 42% and 49%, respectively. High population countries like India has administered 18,58,09,302 vaccine till May 2021 with average daily vaccination accounting 15,10,644. The rapid vaccine drive need more than a billion vials to be manufactured and shipped at top speed. The leading companies have been expanding their product portfolio to cater to the global demand. For instance, Neville and More have launched an original line of type 1 tubular glass vials and ampoules. These Borosilicate glass vials cover an extensive from 2ml to 100ml sizes so that the vials can be duly used for tasks and functions.
In 2020, Stevanato Group signed an agreement with the Coalition for Epidemic Preparedness Innovations to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development. Moreover, in 2021, Stevanato Group has agreed with Corning Incorporated to offer biopharmaceutical companies with higher levels of protection for injectable drugs while enabling smooth manufacturing operations.

The shortage of vials amid huge demand is likely to hinder the market growth

The pharmaceutical vials market is impacted by the shortage of vials amid huge demand for packaging vaccines. The University of Oxford reported the potential glass shortage, claiming the availability of 200 million vials left in the world. Moreover, with rapid vaccine trials, leading companies Pfizer and BioNTech and Moderna have recognised a shortage of vials to package the vaccine is one of the major factors responsible for restraining the market growth.

COVID-19 Impact Analysis on Pharmaceutical Vials Market

Due to the pandemic, stakeholders across the pharmaceutical vials industry have seen an unexpected hype in the market. As a result, companies are working with higher production rates to supply the pharmaceutical vials for covid vaccines. Moreover, the government has been making huge investments in the market to avoid the global shortage of vials in the pandemic situation. For instance, in 2020, Corning Inc. has received $204 million funding from the U.S. government’s Biomedical Advanced Research and Development Authority to increase the production of its glass vials for anticipated coronavirus vaccines. In 2019, the global pharmaceutical industry consumed approximately 12 billion vials for supplying vaccines and essential medicines. For instance, Stevanato Group delivered more than 2 billion vials in 2019. The increasing Covid-19 vaccine trials globally will create the need for additional billions of vials. Also, the occurrence of the second wave of covid-19 globally will hype the market demand for pharmaceutical vials globally.

Market Segmentation Analysis

By material, the pharmaceutical vials market is broadly classified into glass, plastic and borosilicates.

The glass vials are expected to grow at the fastest CAGR during the forecast period (2024-2031)

Glass Vials are expected to hold the largest market for pharmaceutical vials market and are expected to continue their dominance in the forecast period. The huge demand for glass vials is due to its offers better thermal stability for sterilisation, enhanced transparency, superior-excellent barrier properties, impermeability, chemical resistance and lower environmental impact. The companies are engaged in offering more efficient pharmaceutical packaging products due to high pressure from the pharmaceutical manufacturers to reduce wastage. Such as, Schott has added plasma impulse chemical vapor deposition to apply several layers of silicon dioxide molecules to the inside surfaces of glass vials. Stevanato company has forecasted the pandemic to drive up demand for glass vials by 20% over the next two years.
Moreover, the Borosilicate vials market is expected to grow at higher rates in the forecast period. According to a Sio2 Materials Science report, approximately 60 to 70% of pharma companies are coming up with concerns about glass. The company officials also concluded that in2019, seven drug products were being tested in clinical trials with containers, which have grown to 41 now.

Market Geographical Share

North America region holds the largest market for global pharmaceutical vials globally

North America region holds the largest market share for the pharmaceutical vials market globally. Although, every region has seen significant growth in terms pharmaceutical vials market due to ongoing vaccination drives. The U.S. has the largest pharmaceutical industry globally in drug development, production, revenue generation, and acceptance, holding almost 48% of the market share. Moreover, the rapid demand from leading vaccine manufacturers has spiked the demand for pharmaceutical vials in the region. Amid potential opportunities in the market, leading players have been investing in expanding the production. For instance, SiO2 Materials Science has invested $163 million for an expansion at the Auburn facility after signing a major contract to supply vials to the government. In 2020, Honeywell Performance Materials introduced Aclar Edge multilayer barrier bottles and vials as a lightweight alternative to glass for pharmaceutical packaging that outshines plastic containers with moisture barrier and enhanced oxygen barrier.
Also, in 2020, ALK Life Science Solutions and UPPI, LLC, has entered into a three-year partnership for offering glass vials to UPPI members providing unit dose radiopharmaceuticals and positron emission tomography manufacturing of radiopharmaceuticals for use in nuclear imaging tests and treatments.

Market Companies and Competitive Landscape

The pharmaceutical vials market is moderately competitive with the local player’s presence, followed by the global companies, contributing to the significant share in the market growth. In addition, some of the key players contributing to the growth of the market are Pacific Vial Manufacturing Inc, Schott AG, Corning Incorporated, Stevanato Group, ALK Life Science Solutions, DWK Life Sciences Ltd., Gerresheimer AG, Berry Global Inc., West Pharmaceutical Services, Inc., Origin Pharma Packaging and others. Furthermore, the major players are adopting various new strategies to dominate the market, such as expansions, acquisitions and collaborations, contributing to the growth of the pharmaceutical vials market globally.

Corning Incorporated

Overview: Corning Incorporated is a multinational company that specializes in glass, ceramics, and other related materials and technologies including advanced optics, primarily for scientific and industrial applications.
Product Portfolio: The Company offers a wide range of products in advanced optics, corning gorilla glass, display technologies, environmental technologies, life sciences, optical communications and pharmaceutical technologies.
Key Development: In 2020, Corning Incorporated and Pfizer Inc signed a long-term purchase and supply agreement for Corning Valor Glass. The multi-year agreement includes the supply of Valor Glass vials to Pfizer drug products.